A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/185 (2006.01) A61K 31/11 (2006.01) A61K 31/60 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2499501
This invention is directed to methods and compositions which impede the development and progression of diseases associated with subclinical inflammation. Subclinical inflammation is commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. The methods and compositions of the invention are also particularly suited to providing therapy for subclinical inflammation in diabetic and prediabetic patients. Methods of the invention comprise administration of DHA alone and in combination with antiplatelet drugs.
La présente invention concerne des procédés et des compositions qui empêchent le développement et la progression de maladies associées à une inflammation subclinique. L'inflammation subclinique est généralement associée à la maladie cardiovasculaire athérosclérotique, à la maladie coronaire et à la maladie cérébrovasculaire. Les procédés et compositions de l'invention sont aussi particulièrement adaptés à la thérapie de l'inflammation subclinique chez des patients diabétiques et prédiabétiques. Les procédés de l'invention consistent à administrer du DHA seul ou combiné à d'autres médicaments anti-plaquettes.
Arterburn Linda M.
Hoffman James P.
Oken Harry A.
Van Elswyk Mary
Martek Biosciences Corporation
Mbm Intellectual Property Law Llp
LandOfFree
Prophylactic docosahexaenoic acid therapy for patients with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic docosahexaenoic acid therapy for patients with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic docosahexaenoic acid therapy for patients with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1365923